Published in Biochim Biophys Acta on March 20, 1974
Retained folates in the rat. Biochem J (1977) 1.19
Rat hepatic uroporphyrinogen III co-synthase. Purification and evidence for a bound folate coenzyme participating in the biosynthesis of uroporphyrinogen III. Biochem J (1984) 0.88
Purification and physicochemical, kinetic and immunological properties of allosteric serine hydroxymethyltransferase from monkey liver. Biochem J (1980) 0.88
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
The current and future market for veterinarians and veterinary medical services in the United States. J Am Vet Med Assoc (1999) 9.90
Finding protein similarities with nucleotide sequence databases. Methods Enzymol (1990) 6.63
Folate levels and neural tube defects. Implications for prevention. JAMA (1995) 5.42
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med (1998) 4.38
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet (1997) 4.11
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet (1995) 3.70
Translocation as a species conservation tool: status and strategy. Science (1989) 3.31
The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem (1996) 3.26
Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet (1984) 2.85
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA (2001) 2.70
Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med (1993) 2.69
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet (1996) 2.53
Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect (1981) 2.52
Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol (1997) 2.40
Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.40
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature (1985) 2.15
Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci U S A (1980) 2.14
A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res (1998) 2.12
Selective inactivation of the transacylase components of the 2-oxo acid dehydrogenase multienzyme complexes of Escherichia coli. Biochem J (1976) 2.10
Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet (1997) 2.10
A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM (1995) 2.05
The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet (1999) 1.94
A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res (1980) 1.89
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res (1986) 1.75
Placental insufficiency and the small-for-dates baby. Am J Obstet Gynecol (1972) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res (1997) 1.71
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci U S A (1981) 1.70
Status and prospects for success of the endangered species act: a look at recovery plans. Science (1993) 1.68
Vitamin B12 and folate deficiency in later life. Age Ageing (2004) 1.67
The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int (2007) 1.64
An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg (1990) 1.61
Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc (1999) 1.58
Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J (1988) 1.57
Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol (2001) 1.55
Mutagenesis by 9,10-anthraquinone derivatives and related compounds in Salmonella typhimurium. Mutat Res (1976) 1.51
Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul Toxicol Pharmacol (1998) 1.51
Localisation of the vaso-motor centre. J Physiol (1923) 1.51
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci U S A (1986) 1.46
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporos Int (2011) 1.45
Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature (1982) 1.45
Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest (1983) 1.42
The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG (2000) 1.42
Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Proc Natl Acad Sci U S A (1988) 1.41
Antibody response of mice to chemically induced tumors. Proc Natl Acad Sci U S A (1978) 1.41
Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc Natl Acad Sci U S A (1985) 1.39
On the carcinogenicity of cadmium by the oral route. Regul Toxicol Pharmacol (1992) 1.39
Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women. Osteoporos Int (2002) 1.39
Dilemmas in caries diagnosis. J Am Dent Assoc (1993) 1.39
Women and the GMC. Br Med J (Clin Res Ed) (1985) 1.38
Protein antigens of normal and malignant human cells identified by immunoprecipitation with monoclonal antibodies. J Biol Chem (1980) 1.37
Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet (1999) 1.37
A microassay for antibody binding to tumor cell surface antigens using 125I-labelled protein a from Staphylococcus aureus. J Immunol Methods (1977) 1.36
Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treat Rep (1984) 1.35
The burden of illness of osteoporosis in Canada. Osteoporos Int (2012) 1.34
The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun (1976) 1.34
Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J Immunol (1981) 1.27
Hsc70-binding peptides selected from a phage display peptide library that resemble organellar targeting sequences. J Biol Chem (1995) 1.27
The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem (1997) 1.26
Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet (1981) 1.25
The part played by the ala cinerea in vaso-motor reflexes. J Physiol (1925) 1.25
Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat Res (1979) 1.24
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
Imaging of melanoma with L-131-labeled monoclonal antibodies. J Nucl Med (1983) 1.24
Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21
Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM (1997) 1.21
Indirect 125I-labeled protein A assay for monoclonal antibodies to cell surface antigens. J Immunol Methods (1979) 1.20
A highly sensitive method for amino-acid analysis by a double-isotope-labelling technique using dansyl chloride. Eur J Biochem (1973) 1.18
Use of beta-lactamase to hydrolyse interfering antibiotics in vitamin B12 microbiological assay using Lactobacillus leichmannii. Clin Lab Haematol (1990) 1.18
Identification of a new vitamin B 12 binder (transcobalamin 3) in normal human serum. Br J Haematol (1972) 1.18
An amino acid sequence in the active site of lipoamide dehydrogenase from the 2-oxoglutarate dehydrogenase complex of E. coli (Crookes strain). FEBS Lett (1972) 1.16
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2003) 1.16
Assignment of the gene for human melanoma-associated antigen p97 to chromosome 3. Nature (1983) 1.16
Incidence of breast-feeding in a low socioeconomic group of mothers in the United States: ethnic patterns. Pediatrics (1984) 1.15
Respiration of Lactobacillus casei. Can J Microbiol (1968) 1.14
Homocysteine and cardiovascular risk. Am J Clin Nutr (2000) 1.13
Trouble-free microbiologic serum and red cell folate assays. Am J Med Technol (1974) 1.13
Mechanism of choline O-sulphate utilization in fungi. Biochem J (1968) 1.13
Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects? Clin Genet (1997) 1.13
Clinical features and motives among 42 artifactual illness patients. Br J Med Psychol (1983) 1.12
Paget disease of bone: mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet (2001) 1.12
Social support, social influence, ethnicity and the breastfeeding decision. Soc Sci Med (1983) 1.12
Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) (1991) 1.11
Risk factors for low BMD in healthy men age 50 years or older: a systematic review. Osteoporos Int (2008) 1.11
Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem (1998) 1.10
Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther (2008) 1.10
Nuchal cord as a cause of neonatal anemia. Am J Dis Child (1985) 1.10
Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas. Int J Cancer (1978) 1.10